GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Navana Pharmaceuticals PLC (DHA:NAVANAPHAR) » Definitions » Accounts Receivable

Navana Pharmaceuticals (DHA:NAVANAPHAR) Accounts Receivable : BDT0.00 Mil (As of . 20)


View and export this data going back to 2022. Start your Free Trial

What is Navana Pharmaceuticals Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Navana Pharmaceuticals's accounts receivables for the quarter that ended in . 20 was BDT0.00 Mil.

Accounts receivable can be measured by Days Sales Outstanding.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Navana Pharmaceuticals's Net-Net Working Capital per share for the quarter that ended in . 20 was BDTN/A.


Navana Pharmaceuticals Accounts Receivable Historical Data

The historical data trend for Navana Pharmaceuticals's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navana Pharmaceuticals Accounts Receivable Chart

Navana Pharmaceuticals Annual Data
Trend
Accounts Receivable

Navana Pharmaceuticals Semi-Annual Data
Accounts Receivable

Navana Pharmaceuticals Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Navana Pharmaceuticals Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Navana Pharmaceuticals's Days Sales Outstanding for the quarter that ended in . 20 is calculated as:

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Navana Pharmaceuticals's accounts receivable are only considered to be worth 75% of book value:

Navana Pharmaceuticals's Net-Net Working Capital Per Share for the quarter that ended in . 20 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(+0.75 * +0.5 * -N/A
--)/0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Navana Pharmaceuticals Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Navana Pharmaceuticals's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Navana Pharmaceuticals Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Road 4, House 99, Block B, Banani, Dhaka, BGD, 1213
Navana Pharmaceuticals PLC operates its business under two divisions namely Veterinary Division and Human Health Division. Veterinary Division manufactures and markets high-quality veterinary medicine and feed supplements for different segments including poultry, dairy and aqua products. Human Health Division operates its manufacturing facilities in strict compliance with WHO cGMP guidelines for the production of tablets, capsules, oral liquids, ampoules, dry powder vials, powder for suspension, eye drops, creams and ointments.

Navana Pharmaceuticals Headlines

No Headlines